Due to the current global health concerns related to COVID-19, this meeting will be held entirely online.
We look forward to hosting you! Register today to join us in December.
December 7–9, 2020
Steering Committee Meeting
December 11, 2020
Hoda Anton-Culver, Ph.D., is a Distinguished Professor in the Department of Medicine at UCI, The Founding Chair of the Department of Epidemiology in the School of Medicine, and the Director of the Genetic Epidemiology Research Institute (GERI) which focuses on the integration of academic research, education, and community efforts to search for genetic, lifestyle and environmental factors that lead to a wide array of human diseases including cancer, heart and lung disease, and diabetes. GERI brings together a multidisciplinary team of molecular biology and biochemistry, evolutionary biology, genetics, immunology, statistics, bioinformatics, and environmental and behavioral sciences to gain a more comprehensive understanding health and disease in populations.
As an epidemiologist, her research for the last 30 years focuses are on cancer epidemiology and Precision Medicine in large population cohorts, with special emphasis on etiology, molecular genetic characterization, evaluation of genetic-phenotype correlation, and genotype-environment interaction. She is one of the founding PIs of the Teachers Cohort Study and is a co-investigator on the Women Health Initiative. She served on the NCI’s Board of Scientific Advisors as well as many NIH Study Sections.
Dr. Anton-Culver’s research takes advantage of population genetics to predict the proportion of disease that can be attributed to genetic variation and exposure to environmental risk factors in human populations. She leads two precision medicine/big data programs: The NIH funded All of Us program and the Athena/Wisdom Breast Health Network, to study prediction of disease risk and outcomes with emphasis on genetic and environment interactions. Her Ph.D. is in Epidemiology from the University of St. Andrews in Scotland.
Romuladus “Romey” Emeka Azuine, Dr.PH., M.P.H., RN, is a Senior Health Science Administrator and Program Officer (PO) with the All of Us Technology and Platform Development Team where he serves as PO for the Data and Resource Center. Prior to this position, Romey was the Director, Division of Research in Maternal and Child Health Bureau’s (MCHB) Office of Epidemiology and Research at the Health Resources and Services Administration (HRSA). In this role, he provided leadership and direction for the MCHB’s extramural research program comprised of interdisciplinary multi-site research networks and investigator-initiated grants.
Romey has led clinical research and human services programs across the US, Europe, and Africa including the federal workgroup that developed the data and information system for the ACA-funded home visiting program grantees from across the U.S., tribes and territories. Prior to joining MCHB, he served as a Health Care Analyst at the U.S. Government Accountability Office where he conducted healthcare audits at the request of Congressional members. Prior to that, he was the Manager, Clinical Research, at the Children’s National Medical Center, Washington, DC, where he led several NIH and industry-funded studies on hematology, oncology, and immunology. His research interests include health disparities, social determinants of health, global health, HIV/AIDS, and health care provider and patient care relationships.
Romey holds a Doctor of Public Health (Dr.PH.) from Morgan State University; Master’s in Public Health (M.P.H.) from Howard University College of Medicine; a Diploma and Registered Nursing Licensure (DipHE/R.N.) from Kingston University & St. George’s Hospital Medical School, London, U.K. He is an alumnus of the Harvard Kennedy School of Government’s Executive Leadership Education course. He was a scholar-fellow of the NIH Translational Health Disparities Course on Integrating Principles of Science, Practice and Policy in Health Disparities Research; and the Bioethics Intensive Course at the University of Maryland’s School of Medicine. Romey is active in community service and is the Editor-in-Chief, International Journal of Maternal and Child Health and AIDS (IJMA). His research has been published in leading journals including Pediatrics, Health Equity, JAMA Psychiatry, Journal of Urban Health, IJMA, and JAMA Network OPEN.
Mark identifies and nurtures new opportunities and collaborations with companies and organizations to form relationships between these entities and Vibrent Health for mutual benefit, in support Vibrent’s strategic vision and business outcomes. He has held leadership positions product partnerships and technology as director of products and chief technology officer for Center for Behavioral Intervention Technologies. He is also a Principal Investigator of the National Institutes of Health’s Precision Medicine Initiative/All of Us Research Program. He holds a degree from University of Illinois at Urbana-Champaign. Mark has a strong in strong interest in precision medicine and is dedicated to his work at Vibrent because of his desire to help others.
John Chaffins is the Chief Experience Officer for the All of Us Research Program, where he leads efforts to design informative, innovative, and engaging on and offline experiences for participants and researchers interested and/or enrolled in the program. Prior to this role, John served as the director of health innovation design at Wondros, where he led teams that defined, designed, and created custom online environments that forged meaningful, creative, and healthy relationships amongst diverse stakeholders. John led Wondros design efforts with the Collaborative Chronic Care Network (C3N) at Cincinnati Children’s Hospital Medical Center, where ethnography-based behavior design has helped inform the creation of digital tools that allow a nationwide network of patients, family members, physicians, and researchers to collaborate and improve the care of children with Crohn’s disease.
Before joining Wondros, John applied his extensive background in health information management and technology to design, develop, and implement systems that allowed physicians to receive real-time data about their patients in a network of more than 320 acute care hospitals across the country. He has also held directorships at Cross Country Healthcare and JFK Medical Center, among other prominent health care organizations. John has a degree in health information management from The Ohio State University.
Elizabeth Gross Cohn, RN, NP, Ph.D., FAAN was named a 2016 White House Champion of Change in Precision Medicine for her work at the intersection of precision medicine, public health and health equity. She is the Associate Provost for Research for Hunter College, and the Rudin Professor and Associate Dean for Research at the Hunter-Bellevue School of Nursing, City University of New York. She serves as the Engagement Lead Investigator for the New York City Precision Medicine Consortium of the All of Us Research Program, where she is also the chair of the Publication Board and the Incident Notification Board. Her work focuses on urban community-health, engagement of underrepresented communities, community-engaged research and the ethical, legal, social and scientific issues in precision medicine and public health. Her work with a Native American Reservation, the Unchung Nations Initiative to End Diabetes (UNITED) was funded by the Patient-Centered Outcomes Research Institute, and a grant to strengthen resilience in communities (RESCUE) was funded by the New York State Department of Health. She is the co-director of Conversations New York, with a mission to promote more and better public conversations in New York.
Her work has been featured in the New York Times, on National Public Radio’s All Things Considered, in The Atlantic and in Men’s Health. She is the author of an Elsevier cardiology text, Flip and See ECG, now in its fourth edition. She is an alum of the Robert Wood Johnson Nurse Faculty Scholars Program.
Dr. Cohn received her associate degree from Nassau Community College, her bachelor’s degree from the State University of New York at Purchase, her master’s degree and Nurse Practitioner from the State University of New York at Stony Brook and her doctorate from Columbia University.
Francis S. Collins, M.D., Ph.D., was appointed the 16th Director of the National Institutes of Health (NIH) by President Barack Obama and confirmed by the Senate. He was sworn in on August 17, 2009. On June 6, 2017, President Donald Trump announced his selection of Dr. Collins to continue to serve as the NIH Director. In this role, Dr. Collins oversees the work of the largest supporter of biomedical research in the world, spanning the spectrum from basic to clinical research.
Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the international Human Genome Project, which culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. He served as director of the National Human Genome Research Institute at NIH from 1993-2008.
Before coming to NIH, Dr. Collins was a Howard Hughes Medical Institute investigator at the University of Michigan. He is an elected member of the National Academy of Medicine and the National Academy of Sciences, was awarded the Presidential Medal of Freedom in November 2007, and received the National Medal of Science in 2009. In 2020, he was elected as a Foreign Member of the Royal Society (UK) and was also named the 50th winner of the Templeton Prize, which celebrates scientific and spiritual curiosity.
Josh Denny, M.D., M.S., is the Chief Executive Officer of the National Institutes of Health’s All of Us Research Program. He has been involved in All of Us from its inception, first as a member of the Advisory Committee to the (NIH) Director Precision Medicine Initiative Working Group, which developed the program’s initial scientific blueprint. He led the program’s initial prototyping project and served as the principal investigator for the All of Us Data and Research Center.
As a physician scientist, Josh is deeply committed to improving patient care through the advancement of precision medicine. Before joining the NIH, Josh was a Professor of Biomedical Informatics and Medicine, Director of the Center for Precision Medicine, and Vice President for Personalized Medicine at Vanderbilt University Medical Center. In his roles at VUMC, he was both a practicing internist and a researcher. His research interests include use of electronic health records (EHRs) and genomics to better understand disease and drug response. He also led efforts implementing precision medicine to improve patient outcomes. Josh was a leader in the development of phenome‐wide association studies (PheWAS) and phenotype risk scores.
He served as PI for Vanderbilt sites in the Electronic Medical Records and Genomics (eMERGE) Network, Pharmacogenomics Research Network (PGRN), and the Implementing Genomics Into Practice (IGNITE) Network. He is an elected member of the National Academy of Medicine, the American Society for Clinical Investigation, and the American College of Medical Informatics.
Holly is the Deputy Director of Product for the All of Us Research Program. Her product experience is varied, from ballistic missile control centers to enterprise master data management tools to healthcare provider survey tools. The common thread through all of these products is a desire to solve real problems with thoughtfully designed products that serve their users and leave the world a better place.
Holly's curiosity extends outside of work. She is a multipotentialite, which means that she switches hobbies about every 3 months, but some of her longest standing hobbies include: performance theater, dance, music, running, rock climbing, cycling and anything DIY. Ask her about her latest project: the camper van.
Stephanie Devaney, Ph.D., is the Chief Operating Officer of the All of Us Research Program at the National Institutes of Health. In this role she is responsible for overseeing the operations of the All of Us Research Program to ensure the program fulfills its mission of advancing precision medicine research. Prior to this she led the coordination of the Precision Medicine Initiative (PMI) from the Office of the Chief of Staff at the White House. In this role she coordinated the many components of the Initiative and guided the vision of the overall effort, along with the many federal partners. Before joining the White House, Stephanie worked in the Office of the Director at the National Institutes of Health. There she helped advance policies critical to biomedical research and the NIH mission and assisted in the development of programs and research initiatives to advance national scientific priorities. Stephanie received her Ph.D. in molecular genetics from the George Washington University and her B.S. in biology from The Ohio State University.
Holly A. Garriock, Ph.D., is the Acting Director of Division of Scientific Programs for the All of Us Research Program. Holly came to the program from the National Institute of Mental Health, where she managed a research portfolio of child and adolescent depression, anxiety, suicide, and trauma that supported her growth and expertise in the fields of child development and mood disorders. Holly did her undergraduate training in Canada; graduate training at the University of Arizona, where she received her Ph.D. in genetics; and postdoctoral research at the University of California, San Francisco.
After spending a varied career in Southern California that included aerospace engineering and federal civil service, Richard Hochfelder returned to his home state of Florida to enjoy his retirement. In 2013, an HbA1c test indicated that he had prediabetes, which prompted him to make significant lifestyle changes and begin researching practices to maintain his health. Richard successfully reversed his prediabetes and joined the All of Us Research Program, because he wanted to be affiliated with healthy lifestyles.
Debbie Isbell, M.A., is a Product and Program Manager for the Division of Technology and Platform Development in the All of Us Research Program. She serves as the technical team lead for the AoU Genomics campaign and manages participant-facing initiatives supported by the Participant Technology Systems Center award. She has 20 years of extramural program management experience with the NIH Office of the Director. Debbie holds a B.A. in Psychology from the University of Pennsylvania and an M.A. in Clinical Psychology from the Hebrew University of Jerusalem.
Dr. Patricia Izbicki is the Retention Manager for the All of Us SouthEast Enrollment Center. Along with her role at All of Us, her research focuses on understanding the brain mechanisms of complimentary therapies in aging adults and persons with neurodegenerative diseases. Her doctoral work focused on cognitive and motor inhibitory control in aging musicians and non-musicians to ultimately guide in designing accessible and evidence-based music interventions.
Dr. Izbicki is a TEDx speaker, Iowa Woman of Innovation, National Science Foundation Science Communication Fellow, Wakonse Teaching Fellow, and Iowa State University Focus Artist. She served on the Society for Neuroscience Trainee Advisory Committee and is former president of the Society for Neuroscience Ames Chapter.
Daozhong Jin is the Strategic Planning Team Lead for the All of Us Research Program. In this role, she works closely with the All of Us leadership to support the program’s strategic and long-range goal setting and planning efforts. She previously supported the program’s national communications, marketing, and engagement efforts through her roles as the communications advisor to the CEO and the tribal engagement team lead.
Prior to joining All of Us, Daozhong helped launch the NIH Outreach Office to support the Office of the Director’s efforts to build relationships and improve communications with key stakeholders. She has also worked on fundraising, marketing, and public interest campaigns for nonprofit organizations.
Minnkyong Lee (Minnky) is an Engagement Specialist with the All of Us Research Program. She has been with the program since May 2017 primarily working with awardees to identify and disseminate best practices in the engagement and retention of participants and their communities. She came to All of Us from the National Human Genome Research Institute (NHGRI) where she was a postdoctoral researcher. There, she examined the roles of novel metastasis suppressors in breast and prostate cancer using animal models and big data. In addition to her research, Minnky has always demonstrated a strong passion for science education and outreach, which led to teaching and volunteering at various local institutions, including the Koshland Science Museum, Northern Virginia Community College, and University of Maryland. A detail with the Education and Community Involvement Branch at NHGRI near the end of her postdoctoral training led her to her current position with the All of Us Division of Engagement. Her combined experiences in both the laboratory and diverse communities bring a unique perspective to the program in engagement science. Minnky received her Ph.D. in biomedical sciences with a concentration in chromatin biology from Rutgers University and her B.S. in biology from Ewha Womans University in Seoul, Korea.
Kelsey Mayo, Ph.D., is a Scientific Product and Portfolio Manager at Vanderbilt University Medical Center. Dr. Mayo is a multidisciplinary scientist with over 10 years of precision medicine research experience and a founding member of the All of Us Data and Research Center. Dr. Mayo recently led the successful development and launch of the Researcher Workbench, the All of Us Research Program’s cloud-based analysis platform. She began her career as a Beckman Scholar at the Georgia Institute of Technology and later earned her doctorate designing advanced therapeutics as an NSF Graduate Research Fellow at Vanderbilt University. In her current role, Dr. Mayo is dedicated to partnering with the scientific community and finding creative solutions which accelerate biomedical research innovation and translation.
Tiffany Meyer is a Lead Research Assistant/Communications at Cherokee Health Systems. She attended the University of Tennessee, Knoxville where she earned her B.A. in English with an emphasis on Creative Writing and a Minor in Business, and later took additional science classes. Creating poetry has been a passion of hers for as long as she can remember. Lyrics and verses would pop into her head as a small child as she danced around. She has published one piece of poetry in a book with many other poets. Currently, she is working on a collaboration of works. Poetry has been a way to create and reflect about the world around.
Dr. Anji Musick (Addington) joined NIMH as an intramural staff scientist in 2002, where she led the genetics research program in the Child Psychiatry Branch, primarily focusing on the genetics of childhood onset schizophrenia and other severe neurodevelopmental disorders. In 2012, Anji moved to the extramural program at NIMH, administering the Genetics of Mental Illness and Genetic Epidemiology Programs and served as the Branch Chief of the Genomics Research Branch in the Division of Neuroscience and Basic Behavioral Science from 2015-2020. Anji led many large collaborative efforts in her time at NIMH such as the Whole Genome Sequencing for Psychiatric Disorders Program (WGSPD), psychENCODE, psychEMERGE, as well as serving as liaison across NIH and other agencies for special initiatives. In January 2020, Anji joined the All of Us Genomics team as the Program Director for the Genome Center awards. After receiving her B.A. in Psychology from University of Virginia, Anji conducted research on the molecular genetics of type 2 diabetes as a pre-doctoral research fellow at NHGRI for two years. Anji received her M.P.H. and Ph.D. in Genetic Epidemiology from the Johns Hopkins Bloomberg School of Public Health.
Debbie Nickerson is Professor of Genome Sciences and Director of the Northwest Genomics Center at the University of Washington in Seattle, Washington. Her group has helped to pioneer the development of new approaches and tools that have become widely applied in human genetics. Her recent work has focused on the development and application of robust approaches for calling challenging regions of the human genome that are medically informative such as the RH locus for blood typing and CYP2D6 in drug dosing and pharmacogenetics. She has extensively applied massively parallel sequencing to gain new insights into rare Mendelian disorders and common human phenotypes. She is an investigator in many groups in the field of genetic medicine including the All of Us Research Program, the Centers for Mendelian Genomics, the Trans-Omics for Precision Medicine (TOPMed) program, the Clinical Sequencing Exploratory Research consortium, and the Pharmacogenomics Research Network.
Christopher J. O’Donnell, M.D., M.P.H., is the VA Contact Co-Principal Investigator and member of the Executive Committee and Science Committee of the NIH All of Us Research Program. He devoted two decades in the NIH National Heart, Lung and Blood Institute, serving as Associate Director of the Framingham Heart Study and as Tenured Senior Investigator and Chief of Cardiovascular Epidemiology and Human Genomics of the Intramural Research Program. Since 2015, he has served as Chief, Cardiology and Director, Center for Population Genomics, of the Boston VA Healthcare System.
Dr. O’Donnell is an internationally recognized expert in population research focused on genomics and precision medicine. He is a leader of multiple international consortia and research networks, including a co-founder of the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. His major research focuses on discovery of genetic and environmental determinants of clinical and subclinical cardiometabolic disease. His research teams have discovered multiple gene variants for cardiometabolic disease and its risk factors. He is author on >600 peer-reviewed articles and chapters, and he has been listed since 2017 as the top 1% most cited on the Clarivate Analytics Most Highly Cited Researchers lists. Chris received his B.S. from Brown University and his M.D. and M.P.H. from Harvard University. He completed his residency in Internal Medicine and clinical fellowship in Cardiology at the Massachusetts General Hospital. He has been affiliated for the past 25 years on the faculties of the flagship Mass General Brigham hospitals and Harvard Medical School.
Lucila Ohno-Machado, M.D., M.B.A., Ph.D., received her medical degree from the University of São Paulo and her doctoral degree in medical information sciences and computer science from Stanford. She is Associate Dean for Informatics and Technology, and the founding chair of the UCSD Health Department of Biomedical Informatics at UCSD, where she leads a group of faculty with diverse backgrounds in medicine, nursing, informatics, and computer science. Also, she is the PI for the California Precision Medicine Consortium for the NIH All of Us Research Program. Prior to her current position, she was faculty at Brigham and Women’s Hospital, Harvard Medical School and affiliated with the MIT Division of Health Sciences and Technology. Dr. Ohno-Machado is an elected member of the American College of Medical Informatics, the American Institute for Medical and Biological Engineering, the American Society for Clinical Investigation and the National Academy of Medicine. She served as editor-in-chief for the Journal of the American Medical Informatics Association from 2011 to 2018. She directs the patient-centered Scalable National Network for Effectiveness Research, a large clinical data research network covering more than 30 million patients and 12 healthcare systems, and was one of the founders of UC-Research eXchange, a clinical data research network that connected the data warehouses of the five University of California medical centers. She was the director of the NIH-funded National Center for Biomedical Computing iDASH (integrating Data for Analysis, ‘anonymization,’ and Sharing) based at UCSD with collaborators in multiple institutions, as well as other NIH-funded consortia and research projects. Her research focuses on privacy-preserving distributed analytics for healthcare and biomedical sciences. She has received numerous awards for innovations in biomedical informatics.
Evelyn Ortiz was born and raised in New York and resides in Yonkers. She and her two siblings were raised by her single mother, who later adopted five children. Evelyn attended Russell Sage College, where she studied Spanish and international studies. She spent much of her career working for the New York City Housing Authority before retiring.
Evelyn has cerebral palsy and has had many encounters with the health care system throughout her life. She remembers spending time in the hospital three days a week during her childhood, plus several surgeries in college, during which, she says, she was a “guinea pig.” She never saw her cerebral palsy as a hardship, however, and always loved her doctors and the care she received. Evelyn discovered the All of Us Research Program while taking her brother to the hospital one day. She opted to join because she learned at an early age from her mother to do at least one good deed every day. Today, Evelyn is an active member of her church and a passionate advocate who works where she is needed to help reduce barriers for people not receiving equitable health care.
Brad Ozenberger, Ph.D., is the genomics program director for the All of Us Research Program, with primary responsibilities in the areas of genetic analysis and data management. Brad is an expert in genomic sequencing and analysis methods. His research emphasis over this decade has been on effective and responsible use of genomic sequencing in medicine. Brad brings a diverse wealth of experience to the program with a career path through the NIH, academia, and industry. Brad was most recently an assistant professor of medicine at the Washington University in St. Louis School of Medicine. Formerly, he served as the deputy director of the Division of Genomic Medicine at the National Human Genome Research Institute, where he directed the Clinical Sequencing Exploratory Research Program supporting investigations of the practical and the psychosocial implications of introducing genome sequencing into clinical practice. He also was co-director of the Cancer Genome Atlas. Prior to joining the NIH, Brad was a distinguished scientist at Wyeth Pharmaceuticals in Princeton, New Jersey. He received a Ph.D. from the University of Missouri School of Medicine and obtained further training as a postdoctoral fellow in the Department of Biology at Yale University.
Prachi Patel is a communications consultant with the All of Us Research Program who joined the program in September 2017 through a contract with Palladian Partners to spearhead special initiatives. As the national launch event coordinator, she liaised with program staff and consortium members to plan for and execute the program’s nationwide, multi-site national launch on May 6, 2018. Prior to joining the All of Us team, Prachi was the communications director at the United States Agency for International Development Office of HIV/AIDS. She has almost 15 years of public health communications experience and has held communications positions at NIH’s National Center for Complementary and Integrative Health, the Department of Veterans Affairs Office of Public Health, and the American Urological Association. Prachi holds a B.S. in mass communications with a concentration in public relations from Boston University.
Rachele Peterson, M.S., CCRP, is Director of Healthcare Provider Organization Engagement at Vibrent Health, which serves as the Participant Technology Systems Center (PTSC) for the All of Us Research Program. Rachele is the primary leader engaging with HPOs through the digital health platforms for research participants and research staff, guiding strategic efforts around policy development, partner support, engagement and long-term retention, innovation, and quality improvement. Previously as executive director of one of the original HPOs from 2016-2020, Rachele successfully built and sustained a clinical research infrastructure of 130 research staff across 14 enrollment sites in two states to engage and enroll over 38,500 participants from diverse communities.
Shimon Rura is a product manager at Verily focused on the All of Us Researcher Workbench. He has a background in software engineering and product management, including health tech for consumers and researchers as well as education and media. Prior to All of Us, he worked on Verily's disease management products for Diabetes and Mental Health. He holds a B.A. in Computer Science from Williams College.
As a Senior Research Scientist, Dr. Sharma’s primary responsibility is Principal Investigator for NIH’s All of Us Research Program, one component of the national Precision Medicine Initiative. The All of Us Research Program will enroll one million or more participants in a longitudinal research study to build the most diverse research resource, which will then study how individual differences in lifestyle, environment and biological makeup affect our ability to prevent and treat diseases. This is a landmark opportunity to ensure underrepresented populations are contributing to the future of health care. Dr. Sharma’s additional responsibilities include serving as a preceptor to Wesleyan University and UConn students, Safety Officer and a member of the Institutional Review Board.
Dr. Sharma came to the Weitzman Institute in March 2019, after serving as the Project Administrator for the NIDDK Inflammatory Bowel Disease Genetics Consortium, and Administrative Manager in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine. In these roles, she participated in the development of long-term goals and strategic objectives and managed of several interdisciplinary multi-investigator programs. She has extensive experience with managing all aspects of academic research programs at three major academic research institutions: The Jackson Laboratory, Yale University School of Medicine, and the Icahn School of Medicine at Mount Sinai. In these roles, Dr. Sharma served as human resources, grants manager and accountant, project and data manager, communications coordinator, and compliance and regulatory manager.
Dr. Sharma earned a bachelor’s degree from Skidmore College and her Ph.D. from the University of Iowa. She completed her post-doctoral training at the Jackson Laboratory. These experiences, in addition to serving as a manager and supervisor drives her passion to mentor and guide undergraduates and graduates as they explore their career paths.
Sheri Schully, Ph.D., is the Acting Chief Medical and Scientific Officer of the All of Us Research Program. Prior to this role, she was a Team Lead and Senior Advisor for Disease Prevention in the Office of Disease Prevention (ODP). There, she led the effort to systematically monitor NIH investments in prevention research and assess the progress of that research. She also served as the team lead for the Knowledge Integration Team as well as a Program Officer in the Epidemiology and Genomics Research Program at the National Cancer Institute (NCI). She came to NCI as a Presidential Management Fellow in 2005.
Dr. Schully has authored or co-authored more than 70 papers, many focusing on the translation of genomic technologies into clinical and Public Health practice. She earned both a Ph.D. in biological sciences with a concentration in population genetics and a B.S. in zoology with a minor in chemistry from Louisiana State University.
Dr. Scott Topper is Color's Vice President of Clinical Operations. He is responsible for ensuring the accuracy, integrity and reliability of Color’s laboratories and clinical services, across genetics and COVID. Scott is an American Board of Medical Genetics and Genomics-certified molecular geneticist, trained at the University of Chicago. He serves on the ClinGen Sequence Variant Interpretation working group and the American College of Medical Genetics Social Ethical and Legal Issues committee. He is a multiple principal investigator on the All of Us Research Program Broad-Color-LMM Genome Center and a co-principal investigator on the All of Us Research Program Genetic Counseling Resource. Before joining Color, Scott was the Head of Clinical Genomics at Invitae, where he led the development and operations of clinical diagnostic testing.
Julia Moore Vogel is Director, Research Implementation for the All of Us Research Program at Scripps Research. Julia manages data and biosample collection for the Direct Volunteer portion of the All of Us Research Program, which aims to enroll and retain 350,000 participants who represent the diversity of the United States. Key components of this effort include collaborating with numerous partners to offer blood and saliva collection nationwide, distributing wearable devices to thousands of participants and evaluating participant engagement, and enabling participants to share data from survey responses to electronic health records.
Prior to SRTI, Julia created, proposed, fundraised for, and implemented research and clinical genomics initiatives at the New York Genome Center and The Rockefeller University. She oversaw the proposal and execution of grants, including a $44M NIH Center for Common Disease Genomics in collaboration with over 20 scientific contributors across seven institutions. She also managed corporate partnerships, including one with IBM that assessed the relative value of several genomic assays for cancer patients. She has a B.S. in Mathematics from RPI, Ph.D. in Computational Biology and Medicine from Cornell and M.B.A. from Cornell.
Dr. Anastasia Wise, is a Program Officer for the Genetic Counseling Resource, with the All of Us Research Program, NIH. She was previously a program director in the Division of Genomic Medicine at the National Human Genome Research Institute (NHGRI). She received her Ph.D. in genetics and genomics from Duke University. Her other research interests include gene-environment interactions in complex disease, pharmaco/toxicogenomics, and ethical, legal, and social issues related to the use of genetic information.
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events